Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.

Treatment consisted of 4-6 cycles of dose-dense intensive chemotherapy incorporating hyperfractionated cyclophosphamide/ifosfamide, high-dose cytarabine and methotrexate, doxorubicin, etoposide, ...

It might also be a treatment for you if you have Burkitt lymphoma, lymphoblastic lymphoma, or diffuse large B-cell lymphoma. You might have IT chemo as a treatment if your doctors find cancer ...

NICE has approved Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for diffuse large B-cell lymphoma (DLBCL ... to 25 years of age with B-cell acute lymphoblastic leukaemia (ALL) that is ...

The trial recruited children and young adults with Philadelphia-negative ALL and lymphoblastic lymphoma (LBL) diagnosed in the United Kingdom and Ireland except those younger than 1 year or with ...

In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...

T cell acute lymphoblastic leukemia (T-ALL)/lymphoblastic lymphoma (LBL). More information on the Phase 1/2 trial is available on clinicaltrials.gov, identifier NCT# 04984356 and on the Phase 2 ...